GenMark Diagnostics (GNMK) Tops Q1 EPS by 4c

GenMark Diagnostics (NASDAQ: GNMK) reported Q1 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $9.53 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Investing.com’s stocks of the week
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy